Rakuten Medical Announces Initiation of Global Phase 3 Trial of ASP-1929 Photoimmunotherapy in Combination with Pembrolizumab for First-Line Recurrent Head and Neck CancerJanuary 23, 2025
Rakuten Medical Announces Initiation of Global Phase 3 Trial of ASP-1929 Photoimmunotherapy in Combination with Pembrolizumab for First-Line Recurrent Head and Neck CancerJanuary 23, 2025
Emergency contraception pill could be an alternative to mifepristone for abortions, study suggestsJanuary 23, 2025
